Epivara
Champaign, US · 1 known investors
Epivara is developing an injectable, permanent alternative to surgical spay and neuter procedures for mammals, intended to be administered in a single shot without anesthesia or incisions. Its products (iSpay, iNeuter, and iNeuter-S) target pets such as cats and dogs, small animals, and livestock in the meat industry to control reproduction and reduce hormone-related issues like boar taint.
AgTechBiotech
Founders & leadership
CJ
Chemyong Jay KoFounder, CEO
EY
Eui Yul ChoiCo-founder
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Agriculture (USDA) | Phase I | 2022 | $175K |
| National Science Foundation | Phase I | 2021 | $254.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Epivara do?
- Epivara is developing an injectable, permanent alternative to surgical spay and neuter procedures for mammals, intended to be administered in a single shot without anesthesia or incisions. Its products (iSpay, iNeuter, and iNeuter-S) target pets such as cats and dogs, small animals, and livestock in the meat industry to control reproduction and reduce hormone-related issues like boar taint.
- Who founded Epivara?
- Epivara was founded by Chemyong Jay Ko, Eui Yul Choi.
- Who are Epivara's investors?
- Epivara's investors include First Leaf Capital.
- Where is Epivara headquartered?
- Epivara is headquartered in Champaign, US.